Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
Blood test tracks lung cancer Drug's effectiveness
Disease control OngoingThis study is exploring if a simple blood test, called a liquid biopsy, can help doctors monitor how well the drug brigatinib is working for patients with a specific type of advanced non-small cell lung cancer. The drug is taken daily to control the cancer. The research aims to s…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated Apr 04, 2026 02:05 UTC
-
Blood test could predict lung cancer survival after treatment
Knowledge-focused OngoingThis study aims to learn if a simple blood test can help predict how well patients with a specific stage of lung cancer will do after treatment. It will observe 100 patients in Spain who have stage IIIA non-small cell lung cancer and are scheduled to receive treatment before surg…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC